Ledipasvir
| CAS No. | 1256388-51-8 |
|---|---|
| MDL No. | MFCD25976756 |
| MF | C49H54F2N8O6 |
| MW | 889.00 |
| InChI Key | VRTWBAAJJOHBQU-KMWAZVGDSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Ledipasvir is a benzimidazole derivative used in combination with sofosbuvir (trade name Harvoni) to treat chronic hepatitis C genotype 1 infection. It functions as an antiviral drug and hepatitis C protease inhibitor. Chemically, it is a carbamate ester, L-valine derivative, bridged compound, carboxamide, benzimidazole, fluorene, organofluorine compound, imidazole, N-acylpyrrolidine, and azaspiro compound.
| CAS No. | 1256388-51-8 |
|---|---|
| Product Name | Ledipasvir |
Associated Conditions
chronic hepatitis C virus infection·COVID-19·hepatitis B virus infection·hepatitis C virus infection·lymphoma·
* The information provided here is compiled from public sources and is for reference only.
